Senate Faces Amendment Gauntlet As User Fee Passage Nears
This article was originally published in The Pink Sheet Daily
Executive Summary
Seventeen amendments will be considered and final passage could come May 24. Along with a ban on generic drug settlements is a proposal to allow members of Congress to observe FDA-industry user fee negotiations.